Cidara Therapeutics, Inc. 4
4 · Cidara Therapeutics, Inc. · Filed Mar 18, 2016
Insider Transaction Report
Form 4
Bartizal Ken
Chief Development Officer
Transactions
- Award
Stock Option (right to buy)
2016-03-16+50,000→ 50,000 totalExercise: $9.89Exp: 2026-03-15→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The option vests in 36 successive equal monthly installments over the three year period beginning on March 16, 2016.